Designer TGFβ superfamily ligands with diversified functionality

PLoS ONE

Volumn 6, Issue 11, 2011, Pages

  Allendorph, George P ^a,b   Read, Jessica D ^c   Kawakami, Yasuhiko ^d   Kelber, Jonathan A ^c   Isaacs, Michael J ^a   Choe, Senyon ^a,b  

^a Gachon University College of Medicine   (South Korea)

^b SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^c SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^d UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN; ACTIVIN BETA A; BONE MORPHOGENETIC PROTEIN; NOGGIN; SMAD1 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; LIGAND;

AMINO TERMINAL SEQUENCE; ARTICLE; CHIMERA; CONTROLLED STUDY; INTRACELLULAR SIGNALING; LIGAND BINDING; MOLECULAR CLONING; PROTEIN ASSEMBLY; PROTEIN ENGINEERING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN REFOLDING; RECEPTOR AFFINITY; RECEPTOR BINDING; AMINO ACID SEQUENCE; METABOLISM; MOLECULAR GENETICS; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; LIGANDS; MOLECULAR SEQUENCE DATA; SEQUENCE HOMOLOGY, AMINO ACID; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 80455145096     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0026402     Document Type: Article

References (53)

1. Roberts AB, Anzano MA, Lamb LC, Smith JM, Sporn MB, (1981) New class of transforming growth factors potentiated by epidermal growth factor: isolation from non-neoplastic tissues. Proceedings of the National Academy of Sciences 78: 5339-5343.
2. Derynck R, Miyazono K, eds. (2008) TGF-beta family (Cold Spring Harbor Monograph Series 50) Cold Spring Harbor Laboratory Press.
3. Beattie GM, Lopez AD, Bucay N, Hinton A, Firpo MT, et al. (2005) Activin A Maintains Pluripotency of Human Embryonic Stem Cells in the Absence of Feeder Layers. Stem Cells 23: 489-495.
4. Puceat M, (2007) TGF-β in the differentiation of embryonic stem cells. Cardiovasc Res 74: 256-261.
5. Bradley L, Yaworsky PJ, Walsh FS, (2008) Myostatin as a therapeutic target for musculoskeletal disease Cellular and Molecular. Life Sciences 65: 2119-2124.
6. Massagué J, (2008) TGF-β in Cancer. Cell 134: 215-230.
7. Massagué J, Blain SW, Lo RS, (2000) TGF-β Signaling in Growth Control, Cancer, and Heritable Disorders. Cell 103: 295-309.
8. Cui Y, Hackenmiller R, Berg L, Jean FO, Nakayama T, et al. (2001) The activity and signaling range of mature BMP-4 is regulated by sequential cleavage at two sites within the prodomain of the precursor. Genes & Development 15: 2797-2802.
9. McDonald NQ, Hendrickson WA, (1993) A structural superfamily of growth factors containing a cystine knot motif. Cell 73: 421-424.
10. Israel DI, Nove J, Kerns KM, Kaufman RJ, Rosen V, et al. (1996) Heterodimeric bone morphogenetic proteins show enhanced activity in vitro and in vivo. Growth Factors 13: 10.
11. Mellor SL, Cranfield M, Ries R, Pedersen J, Cancilla B, et al. (2000) Localization of Activin βA-, βB-, and βC-Subunits in Human Prostate and Evidence for Formation of New Activin Heterodimers of βC-Subunit. J Clin Endocrinol Metab 85: 4851-4858.
12. Butler SJ, Dodd J, (2003) A role for BMP heterodimers in roof plate-mediated repulsion of commissural axons. Neuron 38: 389-401.
13. Shimmi O, Umulis D, Othmer H, O'Connor MB, (2005) Facilitated transport of a Dpp/Scw heterodimer by Sog/Tsg leads to robust patterning of the Drosophila blastoderm embryo. Cell 120: 873-886.
14. Liao WX, Moore RK, Otsuka F, Shimasaki S, (2003) Effect of Intracellular Interactions on the Processing and Secretion of Bone Morphogenetic Protein-15 (BMP-15) and Growth and Differentiation Factor-9. Implication of the Aberrant Ovarian Pheotype of BMP-15 Mutant Sheep. J Biol Chem 278: 3713-3719.
15. Derynck R, Feng X-H, (1997) TGF-β receptor signaling. Biochimica et Biophysica Acta (BBA)- Reviews on Cancer 1333: F105-F150.
16. Laiho M, Weis MB, Massagué J, (1990) Concomitant loss of transforming growth factor (TGF)-beta receptor types I and II in TGF-beta-resistant cell mutants implicates both receptor types in signal transduction. J Biol Chem 265: 18518-18524.
17. Attisano L, Wrana JL, (1996) Signal transduction by members of the transforming growth factor-β superfamily. Cytokine & Growth Factor Reviews 7: 327-339.
18. Shi Y, Massagué J, (2003) Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus. Cell 113: 685-700.
19. Miyazono K, (2000) Positive and negative regulation of TGF-beta signaling. J Cell Sci 113: 1101-1109.
20. Lavery K, Swain P, Falb D, Alaoui-Ismaili MH, (2008) BMP-2/4 and BMP-6/7 Differentially Utilize Cell Surface Receptors to Induce Osteoblastic Differentiation of Human Bone Marrow-derived Mesenchymal Stem Cells. J Biol Chem 283: 20948-20958.
21. Nickel J, Kotzsch A, Sebald W, Mueller TD, (2005) A Single Residue of GDF-5 Defines Binding Specificity to BMP Receptor IB. Journal of Molecular Biology 349: 933-947.
22. Allendorph GP, Isaacs MJ, Kawakami Y, IzpisuaBelmonte JC, Choe S, (2007) BMP-3 and BMP-6 Structures Illuminate the Nature of Binding Specificity with Receptors. Biochemistry 46: 12238-12247.
23. Allendorph GP, Vale WW, Choe S, (2006) Structure of the ternary signaling complex of a TGF-beta superfamily member. Proceedings of the National Academy of Sciences 103: 7643-7648.
24. Long S, Truong L, Bennett K, Phillips A, Wong-Staal F, et al. (2006) Expression, purification, and renaturation of bone morphogenetic protein-2 from Escherichia coli. Protein Expression and Purification 46: 374-378.
25. Ejima D, Ono K, Tsumoto K, Arakawa T, Eto Y, (2006) A novel "reverse screening" to identify refolding additives for activin-A. Protein Expression and Purification 47: 45-51.
26. Pangas SA, Woodruff TK, (2002) Production and purification of recombinant human inhibin and activin. J Endocrinol 172: 199-210.
27. Harrison CA, Gray PC, Fischer WH, Donaldson C, Choe S, et al. (2004) An Activin Mutant with Disrupted ALK4 Binding Blocks Signaling via Type II Receptors. J Biol Chem 279: 28036-28044.
28. Balamurali MM, Sharma D, Chang A, Knor D, Chu R, et al. (2008) Recombination of protein fragments: A promising approach toward engineering proteins with novel nanomechanical properties. Protein Science 17: 1815-1826.
29. Greenwald J, Vega ME, Allendorph GP, Fischer WH, Vale W, et al. (2004) A Flexible Activin Explains the Membrane-Dependent Cooperative Assembly of TGF-[beta] Family Receptors. Molecular Cell 15: 485-489.
30. Greenwald J, Groppe J, Gray P, Wiater E, Kwiatkowski W, et al. (2003) The BMP7/ActRII Extracellular Domain Complex Provides New Insights into the Cooperative Nature of Receptor Assembly. Molecular Cell 11: 605-617.
31. Schier AF, Shen MM, (2000) Nodal signalling in vertebrate development. Nature 403: 385-389.
32. Gray PC, Harrison CA, Vale W, (2003) Cripto forms a complex with activin and type II activin receptors and can block activin signaling. Proceedings of the National Academy of Sciences of the United States of America 100: 5193-5198.
33. Kelber JA, Shani G, Booker EC, Vale WW, Gray PC, (2008) Cripto Is a Noncompetitive Activin Antagonist That Forms Analogous Signaling Complexes with Activin and Nodal. Journal of Biological Chemistry 283: 4490-4500.
34. Blunk T, Sieminski AL, Appel B, Croft C, Courter DL, et al. (2003) Bone Morphogenetic Protein 9: A Potent Modulator of Cartilage Development In Vitro. Growth Factors 21: 71-77.
35. Chen C, Grzegorzewski KJ, Barash S, Zhao Q, Schneider H, et al. (2003) An integrated functional genomics screening program reveals a role for BMP-9 in glucose homeostasis. Nat Biotech 21: 294-301.
36. Brown MA, Zhao Q, Baker KA, Naik C, Chen C, et al. (2005) Crystal Structure of BMP-9 and Functional Interactions with Pro-region and Receptors. J Biol Chem 280: 25111-25118.
37. David L, Mallet C, Mazerbourg S, Feige J-J, Bailly S, (2007) Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells. Blood 109: 1953-1961.
38. Groppe J, Greenwald J, Wiater E, Rodriguez-Leon J, Economides AN, et al. (2002) Structural basis of BMP signalling inhibition by the cystine knot protein Noggin. Nature 420: 636-642.
39. Hemmati-Brivanlou A, Kelly OG, Melton DA, (1994) Follistatin, an antagonist of activin, is expressed in the Spemann organizer and displays direct neuralizing activity. Cell 77: 283-295.
40. Thompson TB, Woodruff TK, Jardetzky TS, (2003) Structures of an ActRIIB:activin A complex reveal a novel binding mode for TGF-[beta] ligand:receptor interactions. EMBO J 22: 1555-1566.
41. Kweon D-H, Lee D-H, Han N-S, Seo J-H, (2004) Solid-Phase Refolding of Cyclodextrin Glycosyltransferase Adsorbed on Cation-Exchange Resin. Biotechnology Progress 20: 277-283.
42. Tsumoto K, Umetsu M, Kumagai I, Ejima D, Philo JS, et al. (2004) Role of Arginine in Protein Refolding, Solubilization, and Purification. Biotechnology Progress 20: 1301-1308.
43. Kirsch T, Sebald W, Dreyer MK, (2000) Crystal structure of the BMP-2-BRIA ectodomain complex. Nat Struct Mol Biol 7: 492-496.
44. Gilboa L, Nohe A, Geissendorfer T, Sebald W, Henis YI, et al. (2000) Bone Morphogenetic Protein Receptor Complexes on the Surface of Live Cells: A New Oligomerization Mode for Serine/Threonine Kinase Receptors. Mol Biol Cell 11: 1023-1035.
45. Song K, Krause C, Shi S, Patterson M, Sutto RK, et al. (2010) Identification of a key residue mediating bone morphogenetic protein (BMP)-6 resistance to noggin inhibition allows for engineered BMPs with superior-agonist activity. J Biol Chem.
46. Seemann P, Brehm A, König J, Reissner C, Stricker S, et al. (2009) Mutations in GDF5 Reveal a Key Residue Mediating BMP Inhibition by NOGGIN. PLoS Genet 5: e1000747.
47. Groppe J, Rumpel K, Economides AN, Stahl N, Sebald W, et al. (1998) Biochemical and Biophysical Characterization of Refolded Drosophila DPP, a Homolog of Bone Morphogenetic Proteins 2 and 4. J Biol Chem 273: 29052-29065.
48. Puck TT, Cieciura SJ, Robinson A, (1958) Genetics of somatic mammalian cells III. Long-term cultivation of euploid cells from human and animal subjects. J Exp Med 108: 945-56.
49. Greenwald J, Fischer WH, Vale WW, Choe S, (1999) Three-finger toxin fold for the extracellular ligand-binding domain of the type II activin receptor serine kinase. Nat Struct Mol Biol 6: 18-22.
50. Nakashima K, Takizawa T, Ochiai W, Yanagisawa M, Hisatsune T, et al. (2001) BMP2-mediated alteration in the developmental pathway of fetal mouse brain cells from neurogenesis to astrocytogenesis. Proc Natl Acad Sci 98: 5868-5873.
51. Yaffe D, Saxel O, (1977) Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. Nature 270: 725-7.
52. Suzuki A, Raya A, Kawakami Y, Morita M, Matsui T, et al. (2006) Nanog binds to Smad1 and blocks bone morphogenetic protein-induced differentiation of embryonic stem cells. Proc Natl Acad Sci 103: 10294-10299.
53. Graham FL, Smiley J, Russell WC, Nairn R, (1977) Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 36: 59-74.